NEWS

FOR IMMEDIATE RELEASE September 6, 2022 STATEMENT FROM NCODA LEGISLATIVE & POLICY ADVISORY COMMITTEE Contact: Kevin Scorsone | NCODA Legislative & Policy Liaison Phone: (919) 903-2057 Email: kevin.scorsone@ncoda.org www.ncoda.org In two consecutive legislative sessions in 2021 and 2022, the state of Maine has focused on reform for patients battling cancer. The legislative bodies in Maine […]

New Approval Alert  The U.S. Food and Drug Administration approved the use of IMBRUVICA® (ibrutinib) for the treatment of pediatric patient one year and older with cGvHD after failure of one or more lines of systemic therapy. Official statement HERE.  

NCODA applauds the recent published article in the American Journal of Managed Care® by our members at Florida Cancer Specialists and Research Institute titled “Defining Appropriate Quality Performance Metrics for Pharmacies Dispensing Oral Oncology Therapies.” Click the link below to read this article: https://www.ajmc.com/view/defining-appropriate-quality-performance-metrics-for-pharmacies-dispensing-oral-oncology-therapies  

Cazenovia, NY, August 16, 2022 –  New cancer treatment therapies, technologies and innovations continue to be discovered and approved for use at a rapid pace, creating an education challenge for physicians and other healthcare professionals within the complex oncology landscape. Working collaboratively with Florida Cancer Specialists & Research Institute, LLC (FCS), NCODA, Inc. developed a […]

Cazenovia nonprofit to host ‘Passion Fore Patients’ Golf Tournament

The NCODA CAWT Tool was recently published in the Journal of Clinical Oncology – Oncology Practice. The article highlights the medication waste associated with external specialty pharmacies compared to Medically Integrated Pharmacies (MIPs), as well as increased cost avoidance demonstrated by MIP teams. As the utilization of oral cancer medications rises, it is vital that cancer centers track costs associated with […]

NCODA University Offers Complimentary Accredited Learning Through Virtual and In-Person Events CAZENOVIA, NY, July 27, 2022 – Empowering all stakeholders in oncology with easily accessible, patient-centered education and collaborative learning opportunities is fundamental to NCODA, Inc. Today, NCODA, launches NCODA University, a new division of the organization, which will allow medically-integrated oncology professionals to obtain […]

FOR IMMEDIATE RELEASE July 14, 2022 STATEMENT FROM NCODA LEGISLATIVE & POLICY ADVISORY COMMITTEE Contact: Kevin Scorsone | NCODA Legislative & Policy Liaison Phone: (919) 903-2057 Email: kevin.scorsone@ncoda.org www.ncoda.org Florida Takes Action Against Prescription Drug Pricing   NCODA is proud to share that on July 8, 2022, Florida Governor Ron DeSantis issued Executive Order 22-164 […]

FOR IMMEDIATE RELEASE July 7, 2022 MEDIA CONTACT: Katie Edmiston Katie.Edmiston@ncoda.org 813-843-1629 CAZENOVIA, NY – NCODA is pleased to announce the appointment of three oncology leaders to the Executive Council: Meg Butler, PharmD (Clearview Cancer Institute), Gury Doshi, MD (Texas Oncology), and Xylina Gregg, MD (Utah Cancer Specialists). “Our Executive Council is comprised of a […]

NCODA recently published an abstract titled “The NCODA PQI: Educating Your Medically Integrated Team While Supporting Better Patient Care with a Concise, Peer-Reviewed,Pharmacy-Led Resource” in the Croatian Journal of Oncology. This abstract is based on a presentation that our Founder & Executive Director, Michael Reff, RPh, MBA, delivered at the Croatian Virtual Congress of Oncology Pharmacy. Click HERE […]

FOR IMMEDIATE RELEASE June 30, 2022 STATEMENT FROM NCODA LEGISLATIVE & POLICY ADVISORY COMMITTEE Contact: Kevin Scorsone | NCODA Legislative & Policy Liaison Phone: (919) 903-2057 Email: kevin.scorsone@ncoda.org www.ncoda.org   NCODA Legislative & Policy Advisory Committee Adds Top Thought Leaders in Oncology NCODA is pleased to announce that Debra Patt, MD, PhD, MBA, Executive Vice […]

NCODA members from a community pharmacy in Canada recently published an article in the Journal of Oncology Pharmacy Practice that aimed to characterize their alignment with the ASCO/NCODA Standards and describe its impact on CDK4/6i treatment use. The authors concluded that a structured, patient-centered pharmacy practice model integrating the ASCO/NCODA Standards ensures timely medication refills, close monitoring, and allows […]